{
    "2018-05-07": [
        [
            {
                "time": "2018-04-25",
                "original_text": "Teva (TEVA) Stock Dips Despite Q1 Earnings & Sales Beat",
                "features": {
                    "keywords": [
                        "Teva",
                        "Q1 earnings",
                        "sales beat",
                        "stock dips"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-04-27",
                "original_text": "Verzenio: Major CDK4/6 Inhibitor in the Future",
                "features": {
                    "keywords": [
                        "Verzenio",
                        "CDK4/6 inhibitor",
                        "future"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-05-03",
                "original_text": "How Amgen’s Nplate, Vectibix, and Neupogen Performed in 1Q18",
                "features": {
                    "keywords": [
                        "Amgen",
                        "Nplate",
                        "Vectibix",
                        "Neupogen",
                        "1Q18 performance"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-05",
                "original_text": "Taltz: Therapy for Psoriasis Indication",
                "features": {
                    "keywords": [
                        "Taltz",
                        "psoriasis",
                        "therapy"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-05-07",
                "original_text": "The Swiss Stock Market Rallied As Nestle Jumps On Starbucks Deal",
                "features": {
                    "keywords": [
                        "Swiss stock market",
                        "Nestle",
                        "Starbucks deal",
                        "rallied"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "consumer goods"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-10",
                "original_text": "Xgeva Could Significantly Boost Amgen’s Revenue Growth in 2018",
                "features": {
                    "keywords": [
                        "Xgeva",
                        "Amgen",
                        "revenue growth",
                        "2018"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-15",
                "original_text": "Sensex, Nifty Modestly Higher In Early Trade",
                "features": {
                    "keywords": [
                        "Sensex",
                        "Nifty",
                        "modestly higher",
                        "early trade"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "index"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}